1.Effect of Phototherapy on Platelet Count in premature Infant.
Heung Kyu KIM ; Young Kyoung PARK
Journal of the Korean Pediatric Society 1983;26(1):34-40
No abstract available.
Blood Platelets*
;
Humans
;
Infant, Newborn
;
Infant, Premature*
;
Phototherapy*
;
Platelet Count*
2.Expressions of p53 and MIB-1 in Glandular Lesions of the Uterine Cervix.
Seo Young PARK ; Mee Young SOL ; Hye Kyoung YOON
Korean Journal of Pathology 1999;33(8):589-595
The glandular lesions of the uterine cervix can be classified into endocervical glandular dysplasia (EGD), adenocarcinoma in situ (AIS) and adenocarcinoma, but the diagnostic criteria and the continuity of endocervical glandular lesions are still controversial. The aim of this study was to evaluate the significance of immunohistochemical findings of p53 and MIB-1 in the discrimination and the continuity of EGD, AIS and adenocarcinoma. The materials for the study included 11 cases of adenocarcinoma, 7 cases of AIS, 12 cases of high grade EGD, and 19 cases of low grade EGD. Also included were eleven benign glandular lesions (5 cases of tuboendometrial metaplasia, 3 cases of mesonephric remnant, 3 cases of microglandular hyperplasia). A strong reaction of more than 5% of the glandular epithelial nuclei was interpreted as positive for p53 protein. MIB-1 expression was analyzed semiquantitatively as negative, 1 , 2 , 3 , depending on the percentage of positive nuclei (less than 1%, 1~9%, 10~39%, > or = 40%, respectively). p53 protein expression was found in 3 (27.3%) out of 11 cases of adenocarcinoma, and 2 (28.6%) out of 7 cases of AIS. But all of high and low grade EGD cases were negative. High MIB-1 labelling index (> or =10%) was found in all adenocarcinoma cases and in 3 (42.9%) out of 7 cases of AIS. But only 2 (17.7%) out of 12 cases of high grade EGD showed high MIB-1 labelling index, and all of low grade EGD and benign lesions showed negligible MIB-1 positivities. In summary, MIB-1 labelling index might be valuable in the discrimination of malignant glandular lesions and endocervical glandular dysplasia from benign lesions, but p53 expression could be a useful parameter in the discrimination of malignant glandular lesions from endocervical glandular dysplasia and benign lesions.
Adenocarcinoma
;
Cervix Uteri*
;
Discrimination (Psychology)
;
Female
;
Metaplasia
3.A case of squamous cell carcinoma arising in benign cystic teratoma of the ovary.
Kyoung Hee PARK ; Young Ho PARK ; Myeong Soon JEUN ; Young Soon KANG ; Hye Kyeong PARK
Korean Journal of Obstetrics and Gynecology 1993;36(7):3107-3111
No abstract available.
Carcinoma, Squamous Cell*
;
Female
;
Ovary*
;
Teratoma*
4.CYP3A5*3 Polymorphism and Its Clinical Implications and Pharmacokinetic Role.
Ji Young PARK ; Yu Jung CHA ; Kyoung Ah KIM
Translational and Clinical Pharmacology 2014;22(1):3-7
The cytochrome P450 (CYP) 3A subfamily is estimated to participate in the biotransformation of 50% of the currently prescribed drugs. Four members of the CYP3A subfamily have been identified in humans: CYP3A4, CYP3A5, CYP3A7, and CYP3A43. Initial data suggested that CYP3A5 accounts for only a small proportion of the total hepatic CYP3A in about 20% of samples, but it was later revealed that CYP3A5 represents more than 50% of the total CYP3A amount in some individuals. Several genetic variants have been described for the CYP3A5 gene, of which the CYP3A5*3 allele (gA6986G), the most common form and leading to the loss of CYP3A5 activity, has been extensively investigated in the aspect of pharmacokinetics and disease risk. This review summarized the molecular characteristics of the CYP3A5 gene, and discusses the association of the CYP3A5*3 polymorphism with disease risks such as cancer and hypertension, along with its role in the pharmacokinetics of CYP3A substrates.
Alleles
;
Biotransformation
;
Cytochrome P-450 CYP3A
;
Cytochrome P-450 Enzyme System
;
Humans
;
Hypertension
;
Pharmacogenetics
;
Pharmacokinetics
5.Estrogen and Progesterone Receptor Expressions in Benign Prostatic Hypertrophy and Prostatic Adenocarcinoma.
Mi Seon KANG ; Seo Young PARK ; Hye Kyoung YOON
Korean Journal of Pathology 1998;32(5):346-351
The effect of androgen in the development of the normal prostate and the evolution of benign prostatic hypertrophy (BPH), and prostatic adenocarcinoma has been proven. In addition to androgen, estrogen and progesterone are also thought to play a role in the pathogenesis of BPH and carcinoma. However, their exact roles are not yet known because there is no conclusive evidence. Thirty cases of prostatic adenocarcinoma and 16 cases of BPH were studied. Immunohistochemical staining for estrogen receptor (ER) and progesterone receptor (PR) in epithelial and stromal cells, respectively was performed and the results were assessed semiquantitatively based on the number of positive cells per 100 total cells. Slides were scored as negative; less than 5% of cells, 1 ; 6~15% of cells, 2 ; 16~25% of cells, and 3 ; more than 26% of cells. The relationship between ER and PR expression and the patient's age, histologic grade, and clinical stage was evaluated in prostatic adenocarcinomas. ER was negative in epithelial and in stromal cells for all prostatic adenocarcinomas and BPH cases. The PR expression in epithelial cells and in stromal cells of BPH was noted in 15 (93.8%) and 16 (100.0%) out of 16, respectively. The PR expression of carcinoma cells and stromal cells in prostatic adenocarcinoma was found in 28 (93.3%) and 23 out of 30 (76.7%), respectively. The PR immunoreactivities of stromal cells around carcinoma were 3 in 18 cases, 2 in one case, and 1 in 4 cases, but those of epithelial and stromal cells of BPH and carcinoma cells of prostatic carcinoma were similar to each other with a value of 3 in most cases. The PR expression rate of stromal cells around carcinoma was significantly correlated with the patient's age (p=0.044), but not with histologic grade and clinical stage. In summary, estrogen does not have a direct effect on the biological behavior of BPH and prostatic adenocarcinoma, but progesterone appears to play a role in the pathogenesis of BPH and prostatic adenocarcinoma. Further studies should clarify the biological role of progesterone in the human prostate.
Adenocarcinoma*
;
Epithelial Cells
;
Estrogens*
;
Humans
;
Progesterone*
;
Prostate
;
Prostatic Hyperplasia*
;
Receptors, Progesterone*
;
Stromal Cells
7.A case of multiple endobronchial hamartomas.
Sung Kyu PARK ; Kyoung Joo RHEE ; Mee Ja PARK ; Sun Young KIM
Tuberculosis and Respiratory Diseases 1992;39(1):83-88
No abstract available.
Hamartoma*
8.A clinical and bacteriologic studies on urinary tract infection.
Kyoung Hee PARK ; Min Ok JANG ; Hong Jun CHO ; Hye Soon PARK ; Young Sik KIM
Journal of the Korean Academy of Family Medicine 1991;12(6):28-37
No abstract available.
Urinary Tract Infections*
;
Urinary Tract*
9.Expression pattern of Hepatitis B Viral Core Antigen (HBcAg) and Surface Antigen (HBsAg) in Liver of the Inactive HBsAg Carriers.
Hee Jeong AHN ; Kyoung Ho KIM ; Young Nyun PARK ; Ho Guen KIM ; Chan Il PARK
Korean Journal of Pathology 1990;24(2):120-127
To understand better the complex natural course of HBV infection, the expression patterns of HBcAg and HBsAg in the liver of 51 inactive serum HBsAg carriers (24 CPH and 27 NPD) were studied by immunohistochemical methods. The inactive serum HBsAg carriers were devided into 3 groups by the following expression patterns of serum HBeAg/anti-HBe status and tissue HBcAg and HBsAg. Pattern A (18 cases) : HBeAg+, cHBcAg+ (94.4%), mHBsAg+ (61.1%), pATTERN B (14 cases) : anti-HBe+, nHBcAg+, cHBsAg+, Pattern C (19 cases) : anti-HBe+, HBcAg-, cHBsAg+ (89.5%). There were no significant differences between CPH and NPD, lthough the core free pattern was more common in the latter. The cHBcAg was expressed in 17 of 18 (94.4%) HBeAg seropositive cases but only one of 33 cases with serum anti-HBe, suggesting that the cHBcAg is intimately related to HBeAg. Since the inactive HBsAg carriers also expressed cHBcAg and/or mHBsAg, the necro-inflammatory activity of HBV infected liver is assumed to depend on the host immune response rather than their presence alone
10.Optimum Culture Conditions for Production of Proteinases secreted by Candida albicans , C. tropicalis , and C. parapsilosis.
Choon Myung KOH ; Kyoung Ho LEE ; Woon Seob SHIN ; Joo Young PARK ; Hyun Sook PARK
Journal of the Korean Society for Microbiology 1997;32(4):421-428
In the present study, culture conditions to secrete proteinases from C. albicans, C. tropicalis and C. parapsilosis were examined. All three Candida species were found to secrete proteinases from acceleration phase to stationary phase, although the proteinase activities in culture filtrate were maximal during late exponential or early stationary phase. The proteinase activity in the culture filtrate of C. albicans cells grown at 30'C, was much higher than those grown at either 20 or 37'C. In culture of C. tropicalis and C. parapsilosis, the highest activity was found in culture filtrate grown at 37C. C. albicans secreted proteinases well in medium at initial pH 4.0-7.0. The optimal initial pH of medium for proteinase secretion was 7.0 for C. tropicalis and 5.0-6.0 for C. parapsilosis. All three Candida species secreted proteinases to greater amount in aerobic state. The most effective carbon source for proteinase secretion was xylose, glucose, maltose and sucrose for C. albicans, xylose for C. tropicalis and trehalose for C. parapsilosis. The effects of proteins, hydrolyzed proteins, ammonium sulfate as a sole nitrogen source on proteinase secretion were examined. Bovine serum albumin was the most effective nitrogen source of those tested and a little proteinase activity was detected in the culture filtrates when yeast cells were incubated in the medium containing ammonium sulfate. C. parapsilosis secreted proteinases to greater amount than the other Candida species in all nitrogen sources under study, indicating that C. parapsilosis proteinase would not be a inducible but a constitutive enzyme.
Acceleration
;
Ammonium Sulfate
;
Candida albicans*
;
Candida*
;
Carbon
;
Glucose
;
Hydrogen-Ion Concentration
;
Maltose
;
Nitrogen
;
Peptide Hydrolases*
;
Serum Albumin, Bovine
;
Sucrose
;
Trehalose
;
Xylose
;
Yeasts